Physician profile
Mark Adrian Peterman
NPI 1386752939
$20,787.06
in general payments reported to CMS, 2019-2025
63 companies · $3,033 in 2025
The $3,033 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,066 · 2020: $2,143 · 2021: $3,015 · 2022: $3,578 · 2023: $2,352 · 2024: $3,599 · 2025: $3,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,975 · Travel and Lodging: $925 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $84.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,974.76 |
| Travel and Lodging | $925.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $84.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $2,171.32 | 2019-2025 | Ffrct |
| Abbott Laboratories | $2,134.45 | 2019-2025 | Aveir, Mitraclip, Dragonfly Opstar |
| Janssen Pharmaceuticals, INC | $1,796.93 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,322.51 | 2019-2025 | |
| Amgen INC. | $1,240.89 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $1,024.52 | 2019-2025 | |
| Medtronic, INC. | $832.64 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Merck Sharp & Dohme LLC | $783.12 | 2021-2025 | Verquvo, Capvaxive |
| Genzyme Corporation | $709.83 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $688.97 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $551.54 | 2019-2025 | |
| Amarin Pharma, INC. | $512.03 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $482.67 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $481.69 | 2019-2025 | Farxiga, Brilinta |
| Alnylam Pharmaceuticals INC. | $466.60 | 2021-2023 | Onpattro |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicure Pharma INC. | $446.29 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $437.71 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $375.83 | 2020-2025 | Nexletol |
| Itamar Medical INC | $367.32 | 2021-2024 | Watchpatone |
| Sanofi-Aventis U.S. LLC | $365.90 | 2019-2024 | |
| Boston Scientific Corporation | $332.45 | 2019-2024 | Bodyguardian |
| Cleerly, INC. | $270.79 | 2024-2025 | Cleerly Ischemia, Cleerly Labs |
| Medtronic Vascular, INC. | $252.64 | 2019-2020 | |
| Lundbeck LLC | $215.47 | 2019-2021 | |
| Stryker Corporation | $178.31 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Regeneron Healthcare Solutions, INC. | $172.25 | 2019 | |
| Scpharmaceuticals INC. | $153.52 | 2023-2025 | |
| Recor Medical INC | $149.87 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Shockwave Medical, INC | $131.95 | 2020-2025 | |
| Bridgebio Pharma, INC. | $131.78 | 2025 | Attruby |
| Arbor Pharmaceuticals, INC. | $121.16 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.69 | 2025 | |
| Imperative Care, INC | $119.65 | 2023 | Zoom 88-T Large Distal Platform |
| Kowa Pharmaceuticals America, INC. | $105.29 | 2019-2021 | |
| Chiesi USA, INC. | $90.00 | 2019-2020 | |
| Astellas Pharma US INC | $83.34 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $77.90 | 2024 | Arcalyst |
| W. L. Gore & Associates, INC. | $77.59 | 2023 | Gore Cardioform Septal Occluder |
| Novo Nordisk INC | $76.15 | 2024-2025 | Wegovy, Ozempic |
| Innovation Technologies INC | $71.84 | 2022-2023 | Irrisept |
| Althera Pharmaceuticals LLC | $68.88 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $64.78 | 2019 | |
| Angiodynamics, INC. | $64.60 | 2022-2023 | Alphavac |
| Tactile Systems Technology INC | $61.16 | 2020-2022 | |
| Cvrx, INC. | $52.86 | 2023-2024 | Barostim Neo System |
| Baxter Healthcare | $39.96 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| G Medical Diagnostic Services, INC. | $27.53 | 2022-2023 | Cardiac Monitoring Suite |
| Edwards Lifesciences Corporation | $26.34 | 2019 | |
| Philips North America LLC | $23.51 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $23.07 | 2023 | Inpefa |
| Lilly USA, LLC | $20.68 | 2025 | Zepbound |
| Atricure, INC. | $19.93 | 2023 | |
| Inari Medical, INC. | $19.37 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Azurity Pharmaceuticals, INC. | $17.25 | 2024 | Edarbyclor |
| Kiniksa Pharmaceuticals, LTD. | $16.79 | 2023 | Arcalyst |
| Glaxosmithkline, LLC. | $15.57 | 2025 | Arexvy |
| Inspire Medical Systems, INC. | $15.20 | 2024 | Inspire |
| Preventice Services, LLC | $14.96 | 2021 | |
| Saranas, INC. | $14.78 | 2022 | |
| Surmodics, INC. | $14.12 | 2024 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Bardy Diagnostics, INC. | $14.00 | 2021 | |
| Intact Vascular, INC. | $13.52 | 2019 | |
| Cordis US Corp. | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Peterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.